2010年度高等学校博士学科点专项科研基金（基金号：20102104120008）脂筏调控EGFR介导的胃癌细胞TRAIL耐药的机制研究，3.6万，2011. 1-2013.12

国家自然科学基金青年基金（编号：81201802）Caveolin-1/EGFR/Src 复合物调控胃癌对TRAIL 耐药的机制研究，23.00 万，2013.1-2015.12

辽宁省自然科学基金（编号：2014021069）IGF-1R/Caveolin-1/Src复合物调控胃癌对TRAIL耐药的机制研究，5.0 万，2015.1-2017.12

国家自然科学基金面上项目（编号：81673025）lncRNA-AT作为ceRNA参与TRAIL调控PD-1促进胃癌增殖的机制，53.00 万，2017.1-2020.12

2022年辽宁省自然科学基金计划项目（2022-YGJC-66）基于深度学习的消化道肿瘤靶向及免疫治疗疗效评估及预后研究，25万，2023.1.1至2025.12.31

Lv J, Zhang S, Liu Y, Li C, Guo T, Zhang S, Li Z, Jiao Z, Sun H, Zhang Y, Xu L (徐玲，通讯作者). NR2F1-AS1/miR-190a/PHLDB2 Induces the Epithelial-Mesenchymal Transformation Process in Gastric Cancer by Promoting Phosphorylation of AKT3. Front Cell Dev Biol. 2021;9:688949. (IF:6.081) 

Zhang S, Liu Y, Jiao Z, Li Z, Wang J, Li C, Qu X, Xu L (徐玲，通讯作者). Development and Validation of a Prognostic Nomogram for Gastric Signet Ring Cell Carcinoma: A Multicenter Population-Based Study. Front Oncol. 2021;11:603031. (IF:5.738) 

Lv J, Guo T, Qu X, Che X, Li C, Wang S, Gong J, Wu P, Liu Y, Liu Y, Xu L (徐玲，通讯作者). PD-L1 Under Regulation of miR-429 Influences the Sensitivity of Gastric Cancer Cells to TRAIL by Binding of EGFR. Front Oncol. 2020;10:1067. (IF:6.244) 

Xu L(徐玲), Zhang Y, Qu X, Che X, Guo T, Li C, Ma R, Fan Y, Ma Y, Hou K, Li D, Hu X, Liu B, Yu R, Yan H, Gong J, Liu Y. DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells. Mol Oncol. 2017;11(12):1733-1751. (IF:5.264) 

Xu L (徐玲), Zhang Y, Qu X, Che X, Guo T, Cai Y, Li A, Li D, Li C, Wen T, Fan Y, Hou K, Ma Y, Hu X, Liu Y. E3 Ubiquitin Ligase Cbl-b Prevents Tumor Metastasis by Maintaining the Epithelial Phenotype in Multiple Drug-Resistant Gastric and Breast Cancer Cells. Neoplasia. 2017; 19(4):374-382. (IF:4.994)